Schlafen 12 Is Prognostically Favorable and Reduces C-Myc and Proliferation in Lung Adenocarcinoma but Not in Lung Squamous Cell Carcinoma

SIMPLE SUMMARY: Different subtypes of lung cancer respond differently to treatment. To understand the signaling pathways that dictate the aggressive behavior of lung adenocarcinoma vs. lung squamous cell carcinoma, we performed a survival analysis that demonstrated that the protein Schlafen 12 corre...

Descripción completa

Detalles Bibliográficos
Autores principales: Al-Marsoummi, Sarmad, Pacella, Jonathan, Dockter, Kaylee, Soderberg, Matthew, Singhal, Sandeep K., Vomhof-DeKrey, Emilie E., Basson, Marc D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7650563/
https://www.ncbi.nlm.nih.gov/pubmed/32987632
http://dx.doi.org/10.3390/cancers12102738

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7650563/
https://www.ncbi.nlm.nih.gov/pubmed/32987632
http://dx.doi.org/10.3390/cancers12102738

Ejemplares similares